BIOMAT Database Logo BIOMAT Database Logo

What's new in paraproteinemic demyelinating neuropathy in 2007-2008? 2008

Michael Lunn
Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK. michael.lunn@uclh.org

Research and development in the area of paraproteinemic demyelinating peripheral neuropathy is slower than for some of the other inflammatory neuropathy syndromes. However, 2007-2008 has produced developments in the understanding of the pathogenesis of the neuropathy and the paraprotein, a potential new animal model, easier diagnostics, and two randomized controlled trials with the results of others awaited. This short review summarizes these publications.

UI MeSH Term Description Entries
D010265 Paraproteinemias A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. Gammapathy, Monoclonal,Gammopathy, Monoclonal,Monoclonal Gammopathies,Paraimmunoglobulinemia,Paraimmunoglobulinemias,Paraproteinemia,Plasma Cell Dyscrasias,Monoclonal Gammapathies,Monoclonal Gammopathy,Cell Dyscrasia, Plasma,Dyscrasia, Plasma Cell,Monoclonal Gammapathy,Plasma Cell Dyscrasia
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003711 Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. Clinically Isolated CNS Demyelinating Syndrome,Clinically Isolated Syndrome, CNS Demyelinating,Demyelinating Disorders,Demyelination,Demyelinating Disease,Demyelinating Disorder,Demyelinations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Michael Lunn
What's new in chronic inflammatory demyelinating polyradiculoneuropathy in 2007-2008?
December 2008, Journal of the peripheral nervous system : JPNS,
Michael Lunn
What's new in multifocal motor neuropathy in 2007-2008?
December 2008, Journal of the peripheral nervous system : JPNS,
Michael Lunn
What's new in Guillain-Barré syndrome in 2007-2008?
June 2009, Journal of the peripheral nervous system : JPNS,
Michael Lunn
Paraproteinemic neuropathy.
September 2009, Leukemia & lymphoma,
Michael Lunn
Paraproteinemic Neuropathy.
March 2001, Current treatment options in neurology,
Michael Lunn
Paraproteinemic neuropathy.
February 2007, Neurologic clinics,
Michael Lunn
Demyelinating CMT--what's known, what's new and what's in store?
June 2015, Neuroscience letters,
Michael Lunn
What's New in Neuropathy?
September 2023, Cureus,
Michael Lunn
What's new in hypertension 2007?
February 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Michael Lunn
What's new in hypertension 2008?
January 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!